NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The deal kicks off a new chapter for a massive distressed Loop building and completes one of the most staggering losses of value ever for a Chicago office property.Read More